This post was originally published on this site
Thermo Fisher Scientific announced earnings per share of $5.6 on revenue of $9.27B. Analysts polled by Investing.com anticipated EPS of $5.47 on revenue of $8.73B.
Thermo Fisher Scientific shares are up 13% from the beginning of the year, still down 0.77% from its 52 week high of $534.41 set on July 27. They are under-performing the S&P 500 which is up 17.18% from the start of the year.
Thermo Fisher Scientific’s report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
